Treatment of menopausal vasomotor symptoms

Medical Letter on Drugs and Therapeutics

Volumn 46, Issue 1197-1198, 2004, Pages 98-99

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; NON PRESCRIPTION DRUG;

ADRENERGIC SYSTEM; ARTICLE; CIMICIFUGA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HOT FLUSH; HUMAN; MENOPAUSE; PHYSIOLOGY; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

CIMICIFUGA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, NON-PRESCRIPTION; ESTROGENS; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; PHYTOTHERAPY; PROGESTINS; RANDOMIZED CONTROLLED TRIALS; VASOMOTOR SYSTEM;

EID: 16544362566     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. JE Manson et al (WHI). Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523.
2. The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004; 11:11.
3. A Maclennan et al. Oral estrogen and combined estrogen/progestogen therapy versus placebo for hot flashes. Cochrane Database Syst Rev 2004; 4:CD002978.
4. DF Archer. Percutaneous 17-beta estradiol gel for the treatment of vasomotor symptoms in postmenopausal women. Menopause 2003; 10:516.
5. H Buckler and F Al-Azzawi. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women. BJOG 2003; 110:753.
6. Menostar - A Low-Dose Estrogen Patch for Osteoporosis. Med Lett Drugs Ther 2004; 46:69.
7. A progestin-releasing intrauterine device for long-term contraception. Med Lett Drugs Ther 2001; 43:7.
8. The North American Menopause Society. Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause 2003; 10:113.
9. AB Vereide et al. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol 2003; 91:526.
10. Choice of Contraceptives. Treat Guidel Med Lett 2004; 2:55.
11. RF Casper et al. The effect of 20 mcg ethinyl estradiol/1 mg norethindrone acetate (Minestrin), a low dose oral contraceptive, on vaginal bleeding patterns, hot flashes, and quality of life in symptomatic perimenopausal women. Menopause 1997; 4:139.
12. CL Loprinzi et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000; 356:2059.
13. CL Loprinzi et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20:1578.
14. V Stearns et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003; 289:2827.
15. M Nagamani et al. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 1987; 156:561.
16. T Guttuso Jr. et al. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003; 101:337.
17. DL Barton et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495.
18. EE Krebs et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104:824.
19. JS Jacobson et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19:2739.
20. Problems with Dietary Supplements. Med Lett Drugs Ther 2002; 44:84.
21. www.clinicaltrials.gov.